fda warning letters glp-1 compounders october 2025 September 15, 2025: Telehealth company must stop implying its compounded GLP -1 is FDA-approved, warns – Partnership for Safe Medicines FDA Sends Warning Letters to
Description
February 18, 2026
But with Direct Meds, the choice is easy
This study was reported in accordance with the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) statement guidelines for cohort studies [27] which is listed in the supplementary information
Endocrinology 149 (5), 20382047
Choose flexibility over perfection: Having both flavored and plain options gives you more control
Amendments were documented in updated study protocols available on ClinicalTrials.gov
